Filing Details
- Accession Number:
- 0001209191-22-054326
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-21 19:02:01
- Reporting Period:
- 2022-10-20
- Accepted Time:
- 2022-10-21 19:02:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1408443 | Milestone Pharmaceuticals Inc. | MIST | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1772891 | K. Debra Liebert | C/O Milestone Pharmaceuticals Inc. 1111 Dr. Frederik-Philips Blvd, Ste 420 Montr?Al A8 H4M 2X6 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2022-10-20 | 10,000 | $5.29 | 10,000 | No | 4 | P | Indirect | By: The Rodriguez and Liebert Revocable Trust |
| Common Shares | Acquisiton | 2022-10-21 | 4,000 | $5.26 | 4,000 | No | 4 | P | Indirect | By: Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By: The Rodriguez and Liebert Revocable Trust |
| No | 4 | P | Indirect | By: Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 127 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.24 to $5.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- These shares are held in a trust for the benefit of several including the Reporting Person's spouse. The Reporting Person's spouse is a co-executor of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
